A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP

NCT06362759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Diseases
Chronic Kidney Insufficiency
Chronic Renal Diseases
Chronic Renal Insufficiency
Kidney Insufficiency, Chronic
C-Reactive Protein
High Sensitivity C-Reactive Protein
Hs-CRP
hsCRP

Interventions

DRUG: TOUR006 - 50 MG
DRUG: TOUR006 - 25 MG
DRUG: TOUR006 - 15 MG
OTHER: Placebo

Sponsor

Tourmaline Bio, Inc.